Dr. Hector A. Oyarzabal, MD, PA

Dr. Oyarzabal practices at Cano Pcp in Pembroke Pines, Florida.

Dr. Oyarzabal's NPI, 1790874089, was assigned on October 12, 2006. Dr. Oyarzabal graduated from Popular Autonomous University of Puebla State School of Medicine in 1981. Dr. Oyarzabal holds Texas license J0623.

Dr. Oyarzabal's primary practice is Cano Pcp, at 2488 N University Dr, Pembroke Pines, FL 33024 in Broward County. The practice phone is (954) 432-0578.

Dr. Oyarzabal's primary practice is Cano Pcp in Pembroke Pines, Florida. The medical group on file is Athens Family Medicine. Dmand AI also links Dr. Oyarzabal to 2 more group practices and clinics, 1 physician office and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Oyarzabal practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Oyarzabal's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Oyarzabal's licenses on file in 2 states: Texas and Oklahoma.

Dmand AI lists acid reflux, aortic atherosclerois, arthritis, asthma, atrial fibrillation and flutter, chronic anemia, chronic diabetes and chronic hypertension among the conditions Dr. Oyarzabal treats.

CMS data shows 937 Medicare services from Dr. Oyarzabal across 11 procedure codes in 2024, for 231 Medicare patients. Medicare paid $59,988 for them. Every service was in an office.

CMS counts 231 Medicare patients who saw Dr. Oyarzabal in 2024. The largest group is 75 to 84, with 89 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Oyarzabal's median patient age at 63, with 55% women.

In 2024, Dr. Oyarzabal wrote 1,672 Medicare Part D claims for 325 patients. 86% of them were for generic drugs. CMS names the drug for 1,168 of them, across 51 drugs with 11 or more claims each, at $99,998 in total drug cost. In 2023, CMS named 2,424 claims across 73 drugs.

Dr. Oyarzabal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Oyarzabal as offering telehealth.

Dmand AI links 2 papers to Dr. Oyarzabal. The most frequent topics are Amiloride, Chlorides and Intestinal Absorption. Dr. Oyarzabal's most frequent co-author is Joseph H. Sellin, MD.

CMS Open Payments shows 124 general payments to Dr. Oyarzabal from 20 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $522.

Dmand AI lists 1 award for Dr. Oyarzabal, most recently CMS Stage 1 EHR in 2013.

Dr. Oyarzabal graduated from Popular Autonomous University of Puebla State School of Medicine in 1981.

Dr. Oyarzabal is in network with 23 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.